Original Breve
Nicotinamida adenina dinucleótido (NADH) en pacientes con síndrome de fatiga crónica
Nicotinamide adenine dinucleotide (NADH) in patients with chronic fatigue syndrome
Leído
4579
Vecesse ha leído el artículo
4579
Total PDF
0
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 0 | 52 | 52 |
| 2025 5 | 0 | 148 | 148 |
| 2025 4 | 0 | 270 | 270 |
| 2025 3 | 0 | 301 | 301 |
| 2025 2 | 0 | 350 | 350 |
| 2025 1 | 0 | 434 | 434 |
| 2024 12 | 0 | 423 | 423 |
| 2024 11 | 0 | 299 | 299 |
| 2024 10 | 0 | 314 | 314 |
| 2024 9 | 0 | 294 | 294 |
| 2024 8 | 0 | 186 | 186 |
| 2024 7 | 0 | 122 | 122 |
| 2024 6 | 0 | 103 | 103 |
| 2024 5 | 0 | 140 | 140 |
| 2024 4 | 0 | 142 | 142 |
| 2024 3 | 0 | 114 | 114 |
| 2024 2 | 0 | 99 | 99 |
| 2024 1 | 0 | 103 | 103 |
| 2023 12 | 0 | 73 | 73 |
| 2023 11 | 0 | 97 | 97 |
| 2023 10 | 0 | 125 | 125 |
| 2023 9 | 0 | 75 | 75 |
| 2023 8 | 0 | 79 | 79 |
| 2023 7 | 0 | 98 | 98 |
| 2023 6 | 0 | 82 | 82 |
| 2023 5 | 0 | 56 | 56 |
Mostrar todo
